Comparison |
Direct evidence |
Direct evidence |
Indirect evidence |
Indirect evidence |
Network meta-anaalysis |
Network
meta-anaalysis |
|
SMD (95% CI) |
Quality of evidence |
SMD
(95% CI) |
Quality of evidence |
SMD (95% CI) |
Quality of evidence |
ESPB versus placebo |
- |
- |
-22.93(-34.29;-11.57) |
⊕⊕⊝⊝
Low
|
-22.93(-34.29;-11.57) |
⊕⊕⊝⊝
Low
|
PIFB versus placebo |
-6.57(-14.52;1.39) |
⊕⊕⊝⊝
Low
|
-11.97(-28.41;4.46) |
⊕⊝⊝⊝
Very
Low
|
-7.59(-14.75;-0.44) |
⊕⊕⊝⊝
Low
|
TTMPB versus placebo |
-11.47 (-18.36;-4.59) |
⊕⊕⊝⊝
Low
|
-6.07(-22.98;10.84) |
⊕⊝⊝⊝
Very
Low
|
-10.70(-17.08; -4.32) |
⊕⊕⊝⊝
Low
|
ESPB versus PIFB |
- |
- |
-15.34(-28.77;-1.91) |
⊕⊝⊝⊝
Very Low
|
-15.34(-28.77;-1.91) |
⊕⊝⊝⊝
Very
Low
|
ESPB versus TTMPB |
- |
- |
-12.23(-25.25;0.80) |
⊕⊝⊝⊝
Very Low
|
-12.23(-25.25;0.80) |
⊕⊝⊝⊝
Very
Low
|
PIFB versus TTMPB |
-0.50 (-15.42;14.42) |
⊕⊕⊝⊝
Low
|
4.90(-5.61;15.42) |
⊕⊝⊝⊝
Very Low
|
3.11(-5.48;
11.70) |
⊕⊕⊝⊝
Low
|